An Introduction to Waterman Ventures

Tuesday, August 24th, 2:00 PM EST

Watch our 45-minute presentation about Waterman Ventures, Alumni Ventures’ Brown-focused venture capital fund. The discussion will be led by Waterman Ventures’ Managing Partner Ludwig Schulze and Senior Principal Dave Fan (BA ’09) and is open to all alumni and friends of Brown.

During the session, we will discuss:

  • The goal and structure of the fund
  • The value of the Alumni Venture model
  • Some examples of current portfolio companies
  • The benefits of diversifying into venture capital
  • The minimum requirements needed to invest in the fund

* You must be accredited to invest in venture capital

About Your Presenters

Ludwig Schulze | Managing Partner | Waterman Ventures

Ludwig Schulze | Managing Partner | Waterman Ventures

Ludwig has been on all sides of venture — as an entrepreneur, corporate buyer of ventures, and venture capitalist. Before Alumni Ventures, he experienced the daily realities of entrepreneurship as Founder and CEO of a mobile payments venture that served over 12 million people. Earlier, at a Fortune 100 telecommunications manufacturer (Nokia), he held general manager and business development roles that included investing in and acquiring venture-backed businesses. His first experience in venture capital was with an $800 million global fund that focused on enterprise and mobile software both before and after the crash. Ludwig began his career as a strategy consultant with the Boston Consulting Group. He has a BA from Brown University and an MBA from Columbia.

Dave Fan | Senior Principal | Waterman Ventures

Dave Fan | Senior Principal | Waterman Ventures

Dave has held operating roles in sales and business development at venture-backed companies focused on digital health (Zocdoc) and enterprise cloud software (Shibumi). He has also invested as a Venture Partner at NextGen and an LP at CRE Venture Capital. Dave began his career in investment banking and corporate strategy at Deutsche Bank. He has a BA in Economics from Brown.

Follow the Fund